All Stories

  1. Development and implementation of a paediatric patient-accessible electronic health record from day one of life: results of a stakeholder analysis (Preprint)
  2. Antibiotic overuse in children with viral infections: lessons from the SARS-CoV-2 pandemic
  3. Implementation of national recommendations for the care of Ukrainian refugee children in Switzerland: a survey of primary care pediatricians
  4. Chikungunya-Infektionen
  5. Infektionen bei Geflüchteten
  6. Infektionen durch nichttuberkulöse Mykobakterien (NTM)
  7. Knochen- und Gelenkinfektionen Knocheninfektion Gelenkinfektion
  8. Lymphadenitis colli
  9. Tuberkulose
  10. Changements climatiques et propagation de maladies infectieuses
  11. Klimawandel und die Verbreitung von Infektionskrankheiten
  12. Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study
  13. Paediatric bed capacity in Swiss hospitals: a comprehensive analysis
  14. The Association Between Obesity and COVID-19 Severity in Children Differed Between SARS-CoV-2 Variants: A Multicountry Hospital-based Observational Study
  15. Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet)
  16. Sex distribution in tuberculosis disease in children, adolescents, and adults in a low-incidence country: a retrospective population-based cohort study
  17. Coronavirus disease 2019 (COVID-19) in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post–COVID-19 conditions, prevention strategies, and future directions
  18. Rifampicin and its neuroprotective properties in humans – A systematic review
  19. Fever in the Returning Pediatric Traveler
  20. Comparative analysis of salivary cytokine profiles in newly diagnosed pediatric patients with cancer and healthy children
  21. Applied body-fluid analysis by wearable devices
  22. Borrelia burgdorferi infections in children and adolescents in Switzerland – a seroprevalence study 2023/2024 (BOBUINCA)
  23. Inpatient burden of respiratory syncytial virus (RSV) in Switzerland, 2003 to 2021: an analysis of administrative data
  24. Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study
  25. Correction: Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol
  26. Optimizing Early Diagnosis of Infectious Diseases in Migrant and Refugee Children: An Overview of Best Practices and Strategies
  27. Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol
  28. Management of the infant born to a mother with tuberculosis: a systematic review and consensus practice guideline
  29. Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study
  30. Clinical and Laboratory Biomarkers as Predictors of Severity in Pediatric Inflammatory Multisystem Syndrome-temporally Associated With SARS-CoV-2: Data From a Prospective Nationwide Surveillance Study in Switzerland
  31. Microbiological Spectrum of Osteoarticular Infections and Their Management in Mongolian Children
  32. The changing clinical presentation of COVID‐19 in children during the course of the pandemic
  33. Is shorter antibiotic treatment duration increasing the risk of relapse in paediatric acute focal bacterial nephritis?
  34. Ratios from full blood count as markers for TB diagnosis, treatment, prognosis: a systematic review
  35. Cardiac involvement in children with paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): data from a prospective nationwide surveillance study
  36. International Pediatric COVID-19 Severity Over the Course of the Pandemic
  37. Diagnosis and treatment of Lyme disease in children
  38. A diagnostic algorithm for children presenting with peripheral facial nerve palsy and inconclusive diagnosis of neuroborreliosis
  39. Die Macht der Sprache
  40. Le pouvoir des mots
  41. Monocyte, Lymphocyte and Neutrophil Ratios – Easy-to-Use Biomarkers for the Diagnosis of Pediatric Tuberculosis
  42. Tuberculosis Case Detection and Guideline Adherence among Child Contacts in Switzerland: A Retrospective Observational Study
  43. Aerococcus urinae — significance of detection in the paediatric urinary tract: a case series
  44. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia
  45. 11/m mit Schmerzen im linken Bein und Hinken nach Fahrradsturz
  46. Diagnostic challenges within the Bacillus cereus-group: finding the beast without teeth
  47. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study
  48. Associations between salivary cytokines and oral health, age, and sex in healthy children
  49. Infektiologische Versorgung minderjähriger Flüchtlinge am Beispiel der Ukraine
  50. Dosing and Monitoring of Isoniazid in a Preterm, Extremely Low Birth Weight Infant After In Utero Exposure to Mycobacterium tuberculosis: A Case Study and Literature Review
  51. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
  52. Associations between salivary cytokines and oral health, age, and sex in healthy children
  53. Malaria in Refugee Children Resettled to a Holoendemic Area of Sub-Saharan Africa
  54. Paediatric refugees from Ukraine: guidance for health care providers
  55. Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study
  56. Aktualisierte Empfehlungen zur infektiologischen Versorgung von Flüchtlingen im Kindes- und Jugendalter in Deutschland (Stand 30. März 2022), angemeldet als S1-Leitlinie (AWMF-Register Nr. 048-017)
  57. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial
  58. Please stop the Russian-Ukrainian war – children will be more than grateful
  59. The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
  60. Towards Accurate Point-of-Care Tests for Tuberculosis in Children
  61. Strengthening Tuberculosis Services for Children and Adolescents in Low Endemic Settings
  62. Correction to: Factors associated with hospital and intensive care admission in paediatric SARS‑CoV‑2 infection: a prospective nationwide observational cohort study
  63. Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
  64. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study
  65. Apparent life-threatening events and brief resolved unexplained events: management of children at a Swiss tertiary care center
  66. Interseasonal RSV infections in Switzerland – rapid establishment of a clinician-led national reporting system (RSV EpiCH)
  67. Subclinical Tuberculosis in Children: Diagnostic Strategies for Identification Reported in a 6-year National Prospective Surveillance Study
  68. X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children—A Case Report
  69. Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review
  70. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation
  71. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation
  72. Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe
  73. Factors Associated With Hospital and Intensive Care Admission in Paediatric SARS-CoV-2 Infection: A Prospective Nationwide Observational Cohort Study
  74. Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
  75. Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland
  76. TB and COVID-19 in migrants – the need to focus on both conditions
  77. Correlation of Vaccine Responses
  78. HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens
  79. Changes in pediatric infections during the COVID-19 pandemic: ‘a quarantrend for coronials’?
  80. Correction to: Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries?
  81. Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis
  82. Health care provided to recent asylum-seeking and non-asylum-seeking pediatric patients in 2016 and 2017 at a Swiss tertiary hospital - a retrospective study
  83. Pediatric Tuberculosis Disease during Years of High Refugee Arrivals: A 6-Year National Prospective Surveillance Study
  84. Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine
  85. Factors Associated with Hospital and Intensive Care Admission in Paediatric SARS-CoV-2 Infection: A Prospective Nationwide Observational Cohort Study
  86. Additional Concerns Regarding Children With Coronavirus Disease 2019
  87. Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries?
  88. Long-Term Outcomes of Acute Osteoarticular Infections in Children
  89. Characterising the epidemic spread of influenza A/H3N2 within a city through phylogenetics
  90. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects
  91. Asylum-Seeking Children with Medical Complexity and Rare Diseases in a Tertiary Hospital in Switzerland
  92. Correction to: Swiss consensus recommendations on urinary tract infections in children
  93. Age-dependent response of the human nasal epithelium to rhinovirus infection
  94. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
  95. Intermediate monocytes exhibit higher levels of TLR2, TLR4 and CD64 early after congenital heart surgery
  96. Swiss consensus recommendations on urinary tract infections in children
  97. COVID-19 in children: patiently and critically evaluate the scientific evidence
  98. Reasons for admission in asylum-seeking and non-asylum-seeking patients in a paediatric tertiary care centre
  99. Age-dependent response of the human nasal epithelium to rhinovirus infection
  100. Preventable admissions and emergency-department-visits in pediatric asylum-seeking and non-asylum-seeking patients
  101. Characterising the epidemic spread of Influenza A/H3N2 within a city through phylogenetics
  102. The global COVID-19 response must include refugees and migrants
  103. High-resolution influenza mapping of a city reveals socioeconomic determinants of transmission within and between urban quarters
  104. In Reference to The Management of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis: A View Beyond Surgery
  105. Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study
  106. Biological sex influences antibody responses to routine vaccinations in the first year of life
  107. Perspective of asylum-seeking caregivers on the quality of care provided by a Swiss paediatric hospital: a qualitative study
  108. Identification of influenza urban transmission patterns by geographical, epidemiological and whole genome sequencing data: protocol for an observational study
  109. The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses
  110. Medical care for migrant children in Europe: a practical recommendation for first and follow-up appointments
  111. A systematic literature review of reported challenges in health care delivery to migrants and refugees in high-income countries - the 3C model
  112. Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management–a retrospective cohort study in Switzerland
  113. Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis
  114. Tuberculosis screening in migrant children in Switzerland.
  115. The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants
  116. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study
  117. Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania
  118. African Tick-Bite Fever
  119. Clinical impact of the type VI secretion system on virulence of Campylobacter species during infection
  120. Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial
  121. A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis
  122. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany – a case report
  123. Cost-Effectiveness of Tuberculosis Screening for Migrant Children in Low-Incidence countries
  124. Evaluation of the current use of imaging modalities and pathogen detection in children with acute osteomyelitis and septic arthritis
  125. Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe
  126. Alveolar echinococcosis in the liver of an adolescent boy
  127. The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
  128. Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children—A Systematic Review
  129. Cytokine profiling in healthy children shows association of age with cytokine concentrations
  130. Towards better healthcare for migrant and refugee children in Europe
  131. S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter
  132. The spectrum of care for pediatric refugees and asylum seekers at a tertiary health care facility in Switzerland in 2015
  133. Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections
  134. Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections
  135. Kawasaki disease: what the paediatrician needs to know
  136. The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe – A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey
  137. A personalised approach is needed for the management of non-tuberculous mycobacterial cervicofacial lymphadenitis
  138. European shortage of purified protein derivative and its impact on tuberculosis screening practices
  139. Group A Streptococcal Suppurative Arthritis and Osteomyelitis of the Shoulder With Brachial Plexus Palsy in a Newborn
  140. Chikungunya Fever During Pregnancy and in Children: An Overview on Clinical and Research Perspectives
  141. Odontoid Osteomyelitis in Children
  142. Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia
  143. Buccal Fat Pad Herniation in an Infant
  144. Therapeutic Drug Monitoring for Anti-infective Agents in Pediatrics
  145. Nontuberculous Mycobacterial Disease in Children – Epidemiology, Diagnosis & Management at a Tertiary Center
  146. Erratum zu: Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen ≺ 15 Jahren in Deutschland
  147. Tuberculosis in young refugees
  148. Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen ‹ 15 Jahren in Deutschland
  149. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe – A ptbnet survey and review of current guidelines
  150. Diagnostic Tests for Childhood Tuberculosis
  151. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis
  152. The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014
  153. Meropenem-associated severe neutropenia in an infant with brain abscess
  154. Chikungunya in Children
  155. The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis
  156. Bullous Rash in an Adolescent Girl
  157. Actinomyces neuiiIsolated From a 20-Month-Old Girl With Cervical Lymphadenitis
  158. Novel concepts in the epidemiology, diagnosis and prevention of childhood tuberculosis
  159. Question 1: Should newborns of mothers with isolated antibodies to hepatitis B core antigen be immunised?
  160. Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe
  161. Aerococcus urinae: a possible reason for malodorous urine in otherwise healthy children
  162. Tuberkulose im Kindesalter
  163. Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?
  164. Epidemiology of childhood tuberculosis in Switzerland between 1996 and 2011
  165. The Contribution of Non-Conventional T Cells and NK Cells in the Mycobacterial-Specific IFNγ Response in Bacille Calmette-Guérin (BCG)-Immunized Infants
  166. Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?
  167. Positive Linking
  168. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations
  169. To x-ray or not to x-ray? Screening asymptomatic children for pulmonary TB: a retrospective audit
  170. Reply: Bacille Calmette-Guérin Vaccine: Innate Immunity and Nonspecific Effects
  171. Infections in Children Treated With Biological Agents
  172. Fieber ohne Fokus und Fieber unklarer Ursache im Kindesalter
  173. Infektionen
  174. Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases
  175. Interferon-  release assays for the diagnosis of tuberculosis in children
  176. Actinobaculum schaalii an emerging pediatric pathogen?
  177. A Comparative Analysis of Polyfunctional T Cells and Secreted Cytokines Induced by Bacille Calmette-Guérin Immunisation in Children and Adults
  178. The Role of Panton-Valentine Leukocidin in Staphylococcus aureus Musculoskeletal Infections in Children
  179. To TST or not to TST: Is tuberculin skin testing necessary before BCG immunisation in children?
  180. The Influence of Bacille Calmette-Guérin Vaccine Strain on the Immune Response against Tuberculosis
  181. The Age-Related Risk of Co-Existing Meningitis in Children with Urinary Tract Infection
  182. Absence of interferon-gamma release assay conversion following tuberculin skin testing
  183. Tuberculous dactylitis—an easily missed diagnosis
  184. The potential danger of a solely interferon-  release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children
  185. Lessons Learned From an Unusual Presentation of CD3+, CD56− T-Cell Large Granular Lymphocyte Leukemia
  186. Mycobacterium marinum infection following kayaking injury
  187. Perception, attitudes and knowledge regarding the 2009 swine‐origin influenza A (H1N1) virus pandemic among health‐care workers in Australia
  188. Discordance between TSTs and IFN-  release assays: the role of NTM and the relevance of mycobacterial sensitins
  189. Indeterminate Interferon-γ Release Assay Results in Children
  190. Too much of a good thing: Management of BCG vaccine overdose
  191. Interferon-γ Release Assays for the Diagnosis of Tuberculosis
  192. Monkey Bites in Travelers
  193. Mapping the global use of different BCG vaccine strains
  194. A 2 year old girl with fever, cough, and tachypnoea
  195. Human Immunodeficiency Virus-Infected Boy With Stevens-Johnson Syndrome Caused by Nevirapine
  196. To BCG or not to BCG?
  197. Susceptibility of Mycobacterium bovis BCG Vaccine Strains to Antituberculous Antibiotics
  198. Influence of BCG vaccine strain on the immune response and protection against tuberculosis
  199. A Three-Way Comparison of Tuberculin Skin Testing, QuantiFERON-TB Gold and T-SPOT.TB in Children
  200. What the Paediatrician Needs to Know When Pandemic Influenza Arrives in Clinical Practice
  201. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis
  202. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis
  203. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child